Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS

Autor: Dorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, Kurt Bjerregaard Stage, Kurt Højlund, Marianne Andersen

Publikováno v: Endocrine Connections, Vol 7, Iss 3, Pp 1-11 (2018)

Background/aims: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, adrenal hyperactivity and decreased mental health. We aimed to investigate the changes in adrenal activity, metabolic status and mental health in PCOS during tre

Externí odkaz: https://doaj.org/article/7cc329b6d82943c79571d3af65b735d4

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome

Autor: Magda Lambaa Altinok, Jan Erik Henriksen, Marianne Andersen, Dorte Glintborg, Pernille Ravn, Hanne Mumm

Publikováno v: Mumm, H, Altinok, M L, Henriksen, J E, Ravn, P, Glintborg, D & Andersen, M 2016, ' Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome ', Human Reproduction, vol. 31, no. 5, pp. 1105-1112 . https://doi.org/10.1093/humrep/dew046

STUDY QUESTION: What is the prevalence of reactive hypoglycemia (RH) in polycystic ovary syndrome (PCOS) versus age- and body mass index (BMI)-matched healthy controls.SUMMARY ANSWER: The prevalence of RH was increased in PCOS versus controls.WHAT IS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada2a286e813aa0d02211d1abe870b3f
https://doi.org/10.1093/humrep/dew046

Increased thrombin generation in women with polycystic ovary syndrome

Autor: Dorte Glintborg, Johannes Jakobsen Sidelmann, Marianne Andersen, Hanne Mumm, Magda Lambaa Altinok

Publikováno v: Metabolism. 64:1272-1278

Objective Polycystic ovary syndrome (PCOS) is associated with risk factors for cardiovascular disease (CVD) which may be modified by the use of metformin and oral contraceptives (OC). Thrombin generation (TG) measures are risk markers of CVD and addr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b23cc041dece5d8a96cce1f256d66429
https://doi.org/10.1016/j.metabol.2015.06.011

Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome

Autor: Hanne Mumm, Magda Lambaa Altinok, Dorte Glintborg, Jens M. Bruun, Marianne Andersen, Bjørn Richelsen

Publikováno v: Glintborg, D, Mumm, H, Altinok, M L, Richelsen, B, Bruun, J M & Andersen, M 2014, ' Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome ', Journal of Endocrinological Investigation, vol. 37, no. 8, pp. 757-764 . https://doi.org/10.1007/s40618-014-0103-8
Glintborg, D, Mumm, H, Altinok, M L, Richelsen, B, Bruun, J M & Andersen, M 2014, ' Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome ', Journal of Endocrinological Investigation, pp. 757-64 . https://doi.org/10.1007/s40618-014-0103-8

CONTEXT: Central obesity in polycystic ovary syndrome (PCOS) is associated with increased inflammatory markers and increased risk for type 2 diabetes.OBJECTIVE: To evaluate if improved body composition during treatment with metformin (M) vs. oral con

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec9aef0ae9dc98785dc98da264a4639
https://portal.findresearcher.sdu.dk/da/publications/a10ca3dd-aa9b-4c8f-9961-f61e89e56387

Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome

Autor: Dorte Glintborg, Pernille Ravn, Magda Lambaa Altinok, Hanne Mumm, Marianne Andersen, Anne Pernille Hermann

Publikováno v: Glintborg, D, Altinok, M L, Mumm, H, Hermann, P, Ravn, P & Andersen, M 2014, ' Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome ', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 7, pp. 2584-2591 . https://doi.org/10.1210/jc.2014-1135

Context: Central obesity in polycystic ovary syndrome (PCOS) is associated with increased inflammatory markers and increased risk for type 2 diabetes. Objective: The objective of the study was to evaluate whether treatment with metformin (M) or M com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15fd56593bb2cf94a67871aa9a930048
https://pubmed.ncbi.nlm.nih.gov/24742124